Sarah Schwartz, MD
Obstetrics · West Islip, NYNPI 1578588356
Payments from drug & device makers
What this record shows
8 manufacturers reported payments, led by Celularity Inc. at 45.8% of the total.
Across 9 payments — averaging $72.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Celularity Inc.$300
- Boston Scientific$148
- Mayne Pharma Commercial LLC$127
- Distalmotion US$20
- Medicem Inc.$16
- Sumitomo Pharma America, Inc.$15
- plus $27 from 2 others
What the payments were for
- Speaking & faculty fees$30046%
- Food & beverage$35554%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Celularity Inc. | 1 | $300 |
| Boston Scientific | 1 | $148 |
| Mayne Pharma Commercial LLC | 2 | $127 |
| Distalmotion US | 1 | $20 |
| Medicem Inc. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Avion Pharmaceuticals | 1 | $14 |
| Organon | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$655 in reported general payments places this provider in the 60th percentile of 82 obstetrics providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 17 | $9,067 |
| PremproEstrogen,con/M-Progest Acet | 16 | $7,377 |
| Solifenacin Succinate | 11 | $1,236 |
| Clobetasol Propionate | 24 | $819 |
| Estradiol | 21 | $694 |
| Metronidazole | 13 | $537 |
| ValacyclovirValacyclovir Hcl | 22 | $473 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 17 | $464 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 15 | $148 |
| Triamcinolone Acetonide | 12 | $42 |
Paid to pharmacies, not to this prescriber.
Other obstetrics in West Islip
- Arthur JonesMiddletown$13K
- Anna BarbieriNew York$9K
- Mitchell KramerHuntington Station$6K
- Albert AyoubBrooklyn$4K
- Shahnoz RustamovaNew York$4K
- Suzanne LajoieNew York$3K
- Lorranie WilliamsCambria Heights$2K
- Carol LopesSyracuse$2K
- Danielle RooneyLatham$2K
- Samina RaghidValley Stream$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.